ArticleFrontiers in oncology2024

Pooled safety analysis of two phase 3 studies investigating trifluridine/tipiracil plus bevacizumab in patients with metastatic colorectal cancer.

Julien Taieb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.